Suppr超能文献

甲基环己亚硝脲两种标记形式在费希尔344大鼠体内的差异分布及共价结合

Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat.

作者信息

Kramer R A, McMenamin M G, Boyd M R

出版信息

Cancer Chemother Pharmacol. 1985;14(2):150-5. doi: 10.1007/BF00434355.

Abstract

The present study compares the organ distribution and covalent binding of MeCCNU labeled either within the carbamylating [( cyclohexyl-1-14C]MeCCNU; Chx-14C-MeCCNU) or alkylating [( 2-chloroethyl-1,2-14C]MeCCNU; Cle-14C-MeCCNU) region of the compound in an animal model shown to be suitable for studying the nephrotoxicity of the nitrosoureas. Extraction of tissue homogenates with organic solvents of increasing polarity, and subsequent analysis of these extracts by HPLC showed fat to accumulate the highest concentration of parent compound. Kidney accumulated the highest levels of the more polar ether- and methanol-extractable metabolites and/or degradation products of either cyclohexyl-derived or chloroethyl-derived 14C-MeCCNU. Striking differences were apparent in the accumulation, degradation and/or metabolism, and tissue distribution of covalently bound radioactivity for the chloroethyl and cyclohexyl moieties. For example, approximately twice as much cyclohexyl-derived 14C was bound covalently to protein of kidney than to protein of liver or lung. In contrast, approximately twice as much chloroethyl-derived 14C was bound to lung protein than to liver of kidney protein. No radioactivity was bound covalently to tissue DNA following Chx-14C-MeCCNU administration. On the other hand, at 4 h, chloroethyl-derived 14C was irreversibly bound to DNA in the relative amounts of kidney (5.0 nmol/mg), liver (2.7 nmol/mg), and lung (1.25 nmol/mg). These results demonstrate that MeCCNU metabolites and/or degradation products are preferentially accumulated in kidney, a primary target organ for MeCCNU toxicity. Moreover, kidney protein and DNA were subject to extensive carbamylation and alkylation reactions as measured by irreversibly bound cyclohexyl-derived and chloroethyl-derived 14C, respectively. These data suggest that the extent of irreversibly bound drug to tissue macromolecules may be a valid predictor of MeCCNU toxicity. However, the relative toxicological significance of either protein carbamylation or DNA alkylation in mediating MeCCNU-induced nephropathy is not yet understood.

摘要

本研究比较了在动物模型中,标记于化合物氨甲酰化区域([环己基-1-¹⁴C]甲环亚硝脲;Chx-¹⁴C-MeCCNU)或烷基化区域([2-氯乙基-1,2-¹⁴C]甲环亚硝脲;Cle-¹⁴C-MeCCNU)的甲环亚硝脲的器官分布和共价结合情况。该动物模型已被证明适用于研究亚硝基脲的肾毒性。用极性递增的有机溶剂提取组织匀浆,随后通过高效液相色谱法对这些提取物进行分析,结果显示脂肪中积累的母体化合物浓度最高。肾脏中积累的极性更强的醚溶性和甲醇溶性代谢物及/或降解产物的水平最高,这些代谢物及/或降解产物来源于环己基或氯乙基衍生的¹⁴C-MeCCNU。氯乙基和环己基部分在共价结合放射性的积累、降解和/或代谢以及组织分布方面存在明显差异。例如,来源于环己基的¹⁴C共价结合到肾脏蛋白质上的量大约是结合到肝脏或肺脏蛋白质上的两倍。相比之下,来源于氯乙基的¹⁴C结合到肺脏蛋白质上的量大约是结合到肝脏或肾脏蛋白质上的两倍。给予Chx-¹⁴C-MeCCNU后,没有放射性共价结合到组织DNA上。另一方面,在4小时时,来源于氯乙基的¹⁴C以相对量不可逆地结合到肾脏(5.0 nmol/mg)、肝脏(2.7 nmol/mg)和肺脏(1.25 nmol/mg)的DNA上。这些结果表明,甲环亚硝脲的代谢物及/或降解产物优先在肾脏中积累,肾脏是甲环亚硝脲毒性的主要靶器官。此外,分别通过不可逆结合的来源于环己基和氯乙基的¹⁴C测定,肾脏蛋白质和DNA经历了广泛的氨甲酰化和烷基化反应。这些数据表明,药物不可逆结合到组织大分子上的程度可能是甲环亚硝脲毒性的有效预测指标。然而,蛋白质氨甲酰化或DNA烷基化在介导甲环亚硝脲诱导的肾病中的相对毒理学意义尚不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验